Bioregulatory Consulting
Bioregulatory Consulting specialises in the development and registration of drugs and biopharmaceuticals. Penny Field is the Director and Principal Consultant.
Mitchell Clinical Consulting
Mitchell Clinical Consulting specialises in the provision of strategic and operational services for the clinical development of pharmaceutical and biological products for the healthcare industry. A specialist in the provision of clinical development services to biotechnology companies with products in or entering early phase clinical development.
The ERA Consulting Group
The ERA Consulting Group is one of the longest established consulting groups serving the biopharmaceutical industry. ERA has an emphasis on consulting relating to technical, nonclinical and clinical product development and regulatory affairs of biopharmaceutical products
ChemSkill
ChemSkill is a specialist Scientific consultancy that has been providing Regulatory Consulting, Scientific Recruitment and Training services in Australia and overseas for almost 20 years.
Pacific Life Sciences
Pacific Life Sciences has over 30 years experience in the pharmaceutical and healthcare industry. David Wilson is a chemical engineer by training with wide experience in quality, manufacturing, projects, and regulatory affairs.
PPD Development
PPD Development is a leading global contract research organisation providing discovery, development and post-approval services as well as compound partnering programs. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organisations.
Sue Akeroyd and Associates
Sue Akeroyd and Associates are consultants and regulatory strategists to the pharmaceutical, complementary medicine, dietary supplement, cosmetic and food industries.
Voisin Consulting Australia
Voisin Consulting Australia. Headquartered in France, and with offices in the USA, Switzerland, India and Australia, Voisin Consulting assists biotech and med-tech companies in the design and implementation of innovative regulatory strategies. Products include drugs, biologics, medical devices, combination products, advanced therapy products, and borderline products.